Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Journal of the American College of Cardiology
|
May 10, 2006
Comparison of radiation doses from multislice computed tomography coronary angiography and conventional diagnostic angiography
Duncan R Coles, Mary A Smail, Ian S Negus, et al.
European Radiology
|
June 27, 2014
Tube potential can be lowered to 80 kVp in test bolus phase of CT coronary angiography (CTCA) and CT pulmonary angiography (CTPA) to save dose without compromising diagnostic quality
J C L Rodrigues, D Joshi, S M Lyen, et al.
Alimentary Pharmacology & Therapeutics
|
April 11, 2016
Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
P P Gounder, L R Bulkow, M Snowball, et al.
ACS Chemical Neuroscience
|
February 18, 2015
Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats
R Kolanos, J S Partilla, M H Baumann, et al.
Vaccine
|
June 15, 2020
Immunogenicity of the hepatitis A vaccine 20 years after infant immunization
E Mosites, S Seeman, S Negus, et al.
Vaccine
|
March 4, 2000
Hepatitis A vaccine administration: comparison between jet-injector and needle injection
J Williams, L Fox-Leyva, C Christensen, et al.
Journal of Medicinal Chemistry
|
January 14, 2000
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence
J L Neumeyer, J M Bidlack, R Zong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2021
Manipulating Pharmacodynamic Efficacy with Agonist + Antagonist Mixtures: In Vitro and In Vivo Studies with Opioids and Cannabinoids
D E Selley, M L Banks, C M Diester, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 27, 2017
Apparent CB<sub>1</sub> Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model
T W Grim, A J Morales, B F Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1993
Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats
S S Negus, S J Henriksen, A Mattox, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Journal of the American College of Cardiology
|
May 10, 2006
Comparison of radiation doses from multislice computed tomography coronary angiography and conventional diagnostic angiography
Duncan R Coles, Mary A Smail, Ian S Negus, et al.
European Radiology
|
June 27, 2014
Tube potential can be lowered to 80 kVp in test bolus phase of CT coronary angiography (CTCA) and CT pulmonary angiography (CTPA) to save dose without compromising diagnostic quality
J C L Rodrigues, D Joshi, S M Lyen, et al.
Alimentary Pharmacology & Therapeutics
|
April 11, 2016
Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
P P Gounder, L R Bulkow, M Snowball, et al.
ACS Chemical Neuroscience
|
February 18, 2015
Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats
R Kolanos, J S Partilla, M H Baumann, et al.
Vaccine
|
June 15, 2020
Immunogenicity of the hepatitis A vaccine 20 years after infant immunization
E Mosites, S Seeman, S Negus, et al.
Vaccine
|
March 4, 2000
Hepatitis A vaccine administration: comparison between jet-injector and needle injection
J Williams, L Fox-Leyva, C Christensen, et al.
Journal of Medicinal Chemistry
|
January 14, 2000
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence
J L Neumeyer, J M Bidlack, R Zong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2021
Manipulating Pharmacodynamic Efficacy with Agonist + Antagonist Mixtures: In Vitro and In Vivo Studies with Opioids and Cannabinoids
D E Selley, M L Banks, C M Diester, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 27, 2017
Apparent CB<sub>1</sub> Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model
T W Grim, A J Morales, B F Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1993
Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats
S S Negus, S J Henriksen, A Mattox, et al.
Page
of 12